Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omacor and Simvastatin Extension in Mixed Dyslipidemia
NCT00678743Phase 4Completed
- Sponsor
- Provident Clinical Research
- Start
- Aug 2007
- Primary completion
- Aug 2009
- Modality
- Small Molecules
01
Overview
Phase 4, open-label, single-arm trial of omega-3-acid triglycerides in mixed dyslipidemia, sponsored by Provident Clinical Research. Primary endpoint: Median Percent Change in Non-High-Density Lipoprotein Cholesterol at 6 weeks. Started Aug 2007; status: completed.
02
Drugs
omega-3-acid triglycerides
03
Conditions
mixed dyslipidemia
Beyond the preview
Go deeper on NCT00678743.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00678743.